Osaic Holdings
EWTX icon

Osaic Holdings’s Edgewise Therapeutics EWTX Stock Holding History

Osaic Holdings’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Buy
8,694
+211
+2% +$7.27K ﹤0.01% 3969
2026
Q1 		$267K Buy
8,483
+8,075
+1,979% +$233K ﹤0.01% 3908
2025
Q4 		$10.1K Sell
408
-39
-9% -$783 ﹤0.01% 6346
2025
Q3 		$7.21K Sell
447
-671
-60% -$9.52K ﹤0.01% 6559
2025
Q2 		$14.7K Buy
1,118
+997
+824% +$14.4K ﹤0.01% 5927
2025
Q1 		$2.66K Sell
121
-943
-89% -$24.7K ﹤0.01% 6482
2024
Q4 		$28.4K Buy
1,064
+166
+18% +$5.29K ﹤0.01% 5101
2024
Q3 		$24K Sell
898
-89
-9% -$1.77K ﹤0.01% 5262
2024
Q2 		$17.8K Buy
+987
New +$17.2K ﹤0.01% 5423
2023
Q3 		– Sell
-169
Closed -$1.31K – 7428
2023
Q2 		$1.31K Hold
169
– – ﹤0.01% 6800
2023
Q1 		$1.13K Buy
169
+81
+92% +$751 ﹤0.01% 6908
2022
Q4 		$1K Buy
+88
New +$825 ﹤0.01% 6869

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's EWTX Position: Q2 2026 in Review

Osaic Holdings increased its Edgewise Therapeutics (EWTX) stake by 2.5% in Q2 2026, buying an estimated $7.27K and bringing the position to 8,694 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #3969.

Osaic Holdings first reported a position in EWTX in Q4 2022 and has held it in 12 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Osaic Holdings held 8,694 shares of Edgewise Therapeutics worth $353K as of Q2 2026.
  • Osaic Holdings bought 211 Edgewise Therapeutics shares in Q2 2026, an estimated $7.27K.
  • Edgewise Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3969 holding.
  • Osaic Holdings first reported a position in Edgewise Therapeutics in Q4 2022 and has held it in 12 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.